Unerwünschte pulmonale Arzneimittelwirkungen

Schlüsselwörter

Nebenwirkungen - Lunge - Fibrose

Key words

side effects - lung - fibrosis

Literatur

• 1 Angle P, Thomas P, Chiu B, Freedman J. Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome.  Chest. 1997;  112 1697-1699
• 2 Azzam I, Tov N, Elias N, Naschitz J E. Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge.  Postgrad Med. 2006;  82 73-75
• 3 Aronchik J M, Gefter W B. Drug-induced pulmonary disease: An update.  J Thorac Imaging. 1991;  6 19-29
• 4 Bryant D H. Drug-induced pulmonary disease.  Med J Austr. 1992;  156 802-805
• 5 Camus P, Martin W J, Rosenow E C. Amiodarone pulmonary toxicity.  Clin Chest Med. 2004;  25 65-75
• 6 Clayton B D, Hitchcock M G, Williford P M. Minocycline hypersensitivity with respiratory failure.  Arch Dermatol. 1999;  135 139-140
• 7 Cooper J AD, White D A, Matthay R A. Drug-induced pulmonary disease. Part 2: noncytotoxic drugs.  Am Rev Respir Disease. 1986;  133 488-505
• 8 Cooper J AD, Zitnik R J, Matthay R A. Mechanisms of drug-induced pulmonary disease.  Ann Rev Med. 1988;  39 395-404
• 9 Filipek W J. Drug-induced pulmonary disease.  Postgrad Med. 179;  65 131-140
• 10 Foucher P, Biour M, Blayac J P. et al . Drugs that may injure the respiratory system.  Eur Respir J. 1997;  10 265-279
• 11 Grahmann P, Kroegel C. Pulmonale Arzneimittel-Nebenwirkungen.  Arzneimitteltherapie. 2000;  11 337-349
• 12 Hayes D, Anstead M I, Kuhn R J. Eosinophilic pneumonia induced by daptomycin.  J Infection. 2007;  54 e211-e213
• 13 Huggins J T, Sahn S A. Drug-induced pleural disease.  Clin Chest Med. 2004;  25 141-153
• 14 Jarand J, Lee A, Leigh R. Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity.  Practice. 2007;  176 1411-1443
• 15 Lunde H, Hedner T, Samuelsson O. et al . Dyspnoea, asthma and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.  BMJ. 1994;  308 18-21
• 16 Mendez J L, Nadrous H F, Hartman T E, Ryu J H. Chronic nitrofurantoin-induced lung disease.  Mayo Clini Proc. 2005;  80 1298-1302
• 17 Ott M C, Khoor, Leventhal J P, Paterick T E, Burger C D. Pulmonary toxicity in patients receiving low-dose amiodaron.  Chest. 2003;  123 646-651
• 18 Polman A J, van der Werf T S, Tiebosch A TMC, Zijlstra J G. Early-onset phenytoin toxicity mimicking a renopulmonary syndrome.  Eur Respir J. 1998;  11 501-503
• 19 Rosenow E C, Limper A H. Drug-induced pulmonary disease.  Semin Respir Infect. 1995;  10 86-95
• 20 Rosenow E C, Myers J L, Swensen S J, Pisani R J. Drug-induced pulmonary disease - an update.  Chest. 1992;  102 239-250
• 21 Sica D A, Brath L. Angiotensin-converting enzyme inhibition - emerging pulmonary issues relating to cough.  Congestive Heart Failure. 2006;  07 - 08 223-226
• 22 Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia.  Semin Respir Crit Care Med. 2006;  27 192-198